Proscia is a software company accelerating pathology's transition to a digital, data-driven discipline and enabling AI to advance precision medicine. Its Concentriq enterprise pathology platform, precision medicine AI portfolio, and real-world data fuel the development and use of novel therapies and diagnostics to drive the fight against humanity's most challenging diseases, like cancer. 14 of the top 20 pharmaceutical companies and a global network of diagnostic laboratories rely on Proscia's solutions each day.
Free | 12 month subscription available.
Sampling of Non-Small Cell Lung Cancer (NSCLC) solid tumor patient results from 2013 - 2023. Dataset includes digital pathology H&E and IHC images, 500+ gene NGS panel, FISH and other clinical data.
showing 1 - 1